D R Bard, C G Knight, D P Page-Thomas. Show Affiliations »
Abstract
Entities: CellLine Chemical Disease
Mesh: See more » Cell Survival/drug effectsCells, CulturedDaunorubicin/analogs & derivativesDaunorubicin/toxicityDose-Response Relationship, DrugLiposomes/administration & dosage
Substances: See more » LiposomesN-acetyldaunomycinN-butyryldaunorubicinN-octanoyldaunorubicinN-palmitoyldaunorubicinDaunorubicin
Year: 1982 PMID: 7082560 PMCID: PMC2011017 DOI: 10.1038/bjc.1982.121
Source DB: PubMed Journal: Br J Cancer ISSN: 0007-0920 Impact factor: 7.640